Avenue Therapeutics, Inc. (ATXI)
OTCMKTS · Delayed Price · Currency is USD
0.2300
+0.0799 (53.23%)
Mar 18, 2026, 2:12 PM EST
Avenue Therapeutics Market Cap
Avenue Therapeutics has a market cap or net worth of $757.77 thousand as of March 19, 2026. Its market cap has decreased by -75.40% in one year.
Market Cap
757.77K
Enterprise Value
-4.21M
Revenue
1.40M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.23
Market Cap Chart
Since June 27, 2017, Avenue Therapeutics's market cap has decreased from 27.57M to 757.77K, a decrease of -97.25%. That is a compound annual growth rate of -33.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 17, 2026 | 505.73K | -76.65% |
| Dec 31, 2025 | 2.17M | -47.28% |
| Dec 31, 2024 | 4.11M | 92.60% |
| Dec 29, 2023 | 2.13M | -61.53% |
| Dec 30, 2022 | 5.54M | -70.79% |
| Dec 31, 2021 | 18.98M | -80.95% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 27, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lipella Pharmaceuticals | 785.54K |
| Scorpius Holdings | 733.71K |
| Windtree Therapeutics | 726.30K |
| SQZ Biotechnologies Company | 707.79K |
| Bio-Path Holdings | 554.92K |
| Hepion Pharmaceuticals | 503.16K |
| Aibotics | 431.49K |
| Altamira Therapeutics | 412.66K |